Core Scientific, Inc. Form 8-K Summary
Business Context and Reporting Period
Core Scientific, Inc. filed a Current Report on Form 8-K covering an event dated June 8, 2022. The filing concerns an amendment to outstanding restricted stock unit awards under the Mineco Holdings, Inc. 2018 Omnibus Incentive Plan. The Board ratified the amendment on June 14, 2022.
Financial Metrics and Capitalization
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
The amendment affects approximately 50 million shares of common stock subject to outstanding RSUs. Approximately 17 million shares are expected to be canceled and forfeited to satisfy tax-withholding obligations through net settlement. The company previously registered 90,350,332 shares issuable under the 2018 Plan and 24,962,264 shares issuable under RSUs assumed and converted in connection with a prior business combination.
Material Changes Versus the Prior Comparable Period
- The Compensation Committee waived and eliminated the requirement for a change in control or public offering for full vesting of the previously outstanding time-vested RSUs.
- All outstanding RSUs under the 2018 Plan are now subject only to time-based vesting.
- The amendment changes the potential share issuance and withholding profile associated with the awards but does not provide a quantified accounting expense or cash impact.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
Management did not provide operating guidance or an outlook in this filing. The company stated that prior mergers did not satisfy the event-based vesting requirement and significantly reduced the possibility that the requirement would otherwise be met. The amendment was approved as necessary, desirable, and in the best interests of the company and its stockholders.
Investors should consider potential dilution from RSU settlement, the reduction in shares through tax-withholding forfeitures, and any compensation expense or accounting consequences that may be disclosed in subsequent filings. The full amendment will be filed as an exhibit to the company’s Form 10-Q for the quarter ending June 30, 2022.
Facts Investors Should Verify
- The final terms of the RSU Amendment when filed with the Form 10-Q.
- The number of RSUs ultimately settled, forfeited, or otherwise canceled.
- The related stock-based compensation expense, tax-withholding treatment, and any effect on diluted shares outstanding.
- Whether any additional awards or registration statements are affected by the amendment.